August 8, 2008
A Raw Deal, in a Researcher's Eyes
Dispute over an invention highlights problems in technology transfer
The University of Georgia and a former faculty member there stand to make some $70-million from a license on an invention used for the popular eyedrops Restasis, sold by Allergan Inc.
Sound great? Not to Renee L. Kaswan, the former professor of veterinary medicine who for more than a decade has been prodding the institution to be more aggressive in commercializing the invention.
She contends the
This is an article for subscribers only. You may access this article by purchasing a:
Digital or Print Subscription
Web Pass
Already have an account? Log In Now.
-
First Person
-
Notes From Academe
-
Commentary
